Jazz Pharmaceuticals plc (JAZZ) has been under a strong bear grip, hence the stock is down -5.56% when compared to the S&P 500 in the past 4 weeks. However, in the near-term, buying emerged at lower levels and the stock has outperformed the S&P 500 by 6.14% in the past 1 week. The stock has risen by 6.71% in the past week indicating that the buyers are active at lower levels, but the stock is down -7.47% in the past 4 weeks.
The stock has recorded a 20-day Moving Average of 0.14% and the 50-Day Moving Average is 7.67%.The 200 Day SMA reached 7.95% Jazz Pharmaceuticals Public Limited Company has dropped 12.25% during the last 3-month period . Year-to-Date the stock performance stands at -10.33%.
Jazz Pharmaceuticals plc (JAZZ) : The most positive equity analysts on Jazz Pharmaceuticals plc (JAZZ) expects the shares to touch $210, whereas, the least positive believes that the stock will trade at $145 in the short term. The company is covered by 11 Wall Street Brokerage Firms. The average price target for shares are $184.18 with an expected fluctuation of $20.18 from the mean.
For the current week, the company shares have a recommendation consensus of Buy. Jazz Pharmaceuticals plc (NASDAQ:JAZZ): stock was range-bound between the intraday low of $125.65 and the intraday high of $128 after having opened at $126.61 on Fridays session. The stock finally closed in the red at $126.61, a loss of -1.38%. The stock remained in the red for the whole trading day. The total traded volume was 1,072,367 shares. The stock failed to cross $128 in Fridays trading. The stocks closing price on Thursday was $126.04.